HomeINZY • NASDAQ
add
Inozyme Pharma Inc
Previous close
$4.67
Day range
$4.59 - $4.74
Year range
$2.69 - $7.80
Market cap
292.58M USD
Avg Volume
676.62K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 24.34M | 43.47% |
Net income | -23.35M | -34.15% |
Net profit margin | — | — |
Earnings per share | -0.38 | 5.00% |
EBITDA | -24.16M | -44.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 166.15M | 26.90% |
Total assets | 176.94M | 24.79% |
Total liabilities | 58.11M | 51.13% |
Total equity | 118.84M | — |
Shares outstanding | 61.86M | — |
Price to book | 2.43 | — |
Return on assets | -32.22% | — |
Return on capital | -34.53% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -23.35M | -34.15% |
Cash from operations | -24.53M | -38.04% |
Cash from investing | 10.39M | -24.50% |
Cash from financing | 159.00K | -99.21% |
Net change in cash | -13.97M | -186.72% |
Free cash flow | -17.02M | -61.53% |
About
Founded
2015
Headquarters
Website
Employees
59